In this report, we extend those studies by showing that individual CD4+ T cells which synthesize anti-viral CCR5 ligands are ‘self-protected’ against infection with R5 but not X4 isolates of HIV-1 during the primary immune response in vitro. Here, CCR5 is linked to infection.